Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals, Inc.
Plaintiff: Bausch Health Ireland Limited and Salix Pharmaceuticals, Inc.
Defendant: Mylan Pharmaceuticals, Inc.
Case Number: 1:2022cv00085
Filed: September 1, 2022
Court: US District Court for the Northern District of West Virginia
Presiding Judge: Thomas S Kleeh
Nature of Suit: Patent - Abbreviated New Drug Applications (ANDA)
Cause of Action: 35 U.S.C. ยง 271 Patent Infringement
Jury Demanded By: None
Docket Report

This docket was last retrieved on October 28, 2022. A more recent docket listing may be available from PACER.

Date Filed Document Text
October 28, 2022 Filing 17 Joint MOTION to Consolidate Cases by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc.. (Attachments: #1 Proposed Order)(Higginbotham, Daniel)
October 26, 2022 Filing 16 VERIFICATION OF ATTORNEY ADMISSION to Attorneys Bryan C. Diner and Justin J. Hasford. (dk)
October 25, 2022 Filing 15 REPLY to Response to Motion re #7 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM MOTION for Judgment on the Pleadings MOTION to Strike filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc.. (Higginbotham, Daniel)
October 24, 2022 Filing 14 CERTIFICATE OF SERVICE by Mylan Pharmaceuticals, Inc. (Preliminary Claim Construction and Identification of Evidence). (O'Brien, William)
October 24, 2022 Filing 13 CERTIFICATE OF SERVICE by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. certifying service of Plaintiffs' Preliminary Proposed Claim Constructions and Identification of Evidence. (Higginbotham, Daniel)
October 18, 2022 Filing 12 RESPONSE in Opposition re #7 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM MOTION for Judgment on the Pleadings MOTION to Strike filed by Mylan Pharmaceuticals, Inc.. (O'Brien, William)
October 17, 2022 Filing 11 AMENDED DOCUMENT by Mylan Pharmaceuticals, Inc.. Amendment to #10 Certificate of Service correcting Certificate filed in the wrong matter. (Copland, Gordon)
October 14, 2022 Filing 10 CERTIFICATE OF SERVICE by Mylan Pharmaceuticals, Inc. MPIs Rebuttal Claim Construction Positions and Objections. (Copland, Gordon)
October 4, 2022 Filing 9 Plaintiffs' Answer to Defendant's Counterclaims Other Document re #5 Answer to Complaint, Counterclaim filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc.. (Higginbotham, Daniel)
October 4, 2022 Filing 8 Memorandum in Support re #7 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM MOTION for Judgment on the Pleadings MOTION to Strike filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc.. (Higginbotham, Daniel)
October 4, 2022 Filing 7 MOTION TO DISMISS FOR FAILURE TO STATE A CLAIM , MOTION for Judgment on the Pleadings ( Responses due by 10/18/2022), MOTION to Strike by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc.. (Attachments: #1 Exhibit A)(Higginbotham, Daniel)
September 21, 2022 Filing 6 FIRST ORDER AND NOTICE REGARDING DISCOVERY AND SCHEDULING: ***NOTICE TO ATTORNEYS*** : Pursuant to Rule 7.1 of the Federal Rules of Civil Procedure, ALL Non-governmental CORPORATE parties must file a DISCLOSURE STATEMENT with the Court. Forms are available on the Court's Web Site at http://www.wvnd.uscourts.gov/forms.htm Rule 26 Meeting to be held by 10/21/2022. Rule 26 Meeting Report due by 11/4/2022. Discovery due by 11/21/2022. Signed by Chief District Judge Thomas S Kleeh on 9/21/2022. (dk)
September 13, 2022 Filing 5 ANSWER to #1 Complaint, Defenses, COUNTERCLAIM against Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. by Mylan Pharmaceuticals, Inc..(O'Brien, William)
September 2, 2022 Filing 4 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (dk)
September 1, 2022 Filing 3 Corporate Disclosure Statement by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (dk)
September 1, 2022 Filing 2 SUPPLEMENTAL INFORMATION FOR PATENT CASES INVOLVING AN ABBREVIATED NEW DRUG APPLICATION (ANDA) filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. (dk)
September 1, 2022 Filing 1 COMPLAINT against Mylan Pharmaceuticals, Inc., filed by Bausch Health Ireland Limited, Salix Pharmaceuticals, Inc. Filing Fee $402. Receipt #AWVNDC-3544240. (Attachments: #1 Exhibit A - Patent 11,142,549 B2, #2 Exhibit B - Patent 11,319,346 B2, #3 Civil Cover Sheet) (dk)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the West Virginia Northern District Court's Electronic Court Filings (ECF) System

Search for this case: Bausch Health Ireland Limited et al v. Mylan Pharmaceuticals, Inc.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Bausch Health Ireland Limited
Represented By: Daniel R. Higginbotham
Represented By: BRYAN C. DINER
Represented By: JUSTIN JAMES HASFORD
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Salix Pharmaceuticals, Inc.
Represented By: Daniel R. Higginbotham
Represented By: BRYAN C. DINER
Represented By: JUSTIN JAMES HASFORD
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Mylan Pharmaceuticals, Inc.
Represented By: Gordon H. Copland
Represented By: William J O'Brien
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?